Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed the stock exchanges that its trading window will be closed for insiders, designated persons, and their immediate relatives starting Thursday, January 1, 2026. The closure will remain in effect until 48 hours after the company declares its unaudited financial results for the quarter ended December 31, 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015. The date of the board meeting to approve these quarterly results will be announced separately. The intimation was signed by Director Nimit Ghatalia.
This is a standard regulatory filing with no direct impact on shareholders. It simply prevents company insiders from trading shares before the upcoming quarterly results announcement, which is normal practice before earnings releases.